GC Biopharma Corp.
GC Biopharma Corp. has 1 licensing announcement in this dataset, dated 2026-08-27.
- Country / operating region
- South Korea
- Ticker
- 查無
- Headquarters
- Yongin, Republic of Korea
- Founded
- 查無
- Business
- Plasma derivatives and vaccines
- Website
- www.gcbiopharma.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| GC FLU + OVX836 | Influenza nucleoprotein and hemagglutinin | other | 查無 | 2026-08-27 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-08-27 | Osivax | GC FLU + OVX836 | 查無 | 查無 | 查無 | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| Osivax | Worldwide excluding Japan and South Korea | Royalties to GC Biopharma; rate not disclosed. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無